Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 5548
115th Congress(2017-2018)
Water, Cosmetics, and Unwanted Pharmaceuticals Study Act
Introduced
Introduced
Introduced in House on Apr 18, 2018
Overview
Text
Introduced in House 
Apr 18, 2018
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Apr 18, 2018)
Apr 18, 2018
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 5548 (Introduced-in-House)


115th CONGRESS
2d Session
H. R. 5548


To require the Administrator of the Environmental Protection Agency to conduct a study on the presence of pharmaceuticals and personal care products in sources of drinking water.

IN THE HOUSE OF REPRESENTATIVES

April 18, 2018

Ms. Schakowsky introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To require the Administrator of the Environmental Protection Agency to conduct a study on the presence of pharmaceuticals and personal care products in sources of drinking water.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Water, Cosmetics, and Unwanted Pharmaceuticals Study Act”.

SEC. 2. Presence of pharmaceuticals and personal care products in sources of drinking water.

Subsection (a) of section 1442 of the Safe Drinking Water Act (42 U.S.C. 300j–1) is amended by adding at the end the following:

“(11) Presence of pharmaceuticals and personal care products in sources of drinking water.—

“(A) STUDY.—The Administrator shall carry out a study on the presence of pharmaceuticals and personal care products in sources of drinking water, which shall—

“(i) identify pharmaceuticals and personal care products that have been detected in sources of drinking water and the levels at which such pharmaceuticals and personal care products have been detected;

“(ii) identify the sources of pharmaceuticals and personal care products in sources of drinking water, including point sources and nonpoint sources of pharmaceutical and personal care products;

“(iii) identify the effects of such pharmaceuticals and personal care products on humans, the environment, and the safety of drinking water; and

“(iv) identify methods to control, limit, treat, or prevent the presence of such pharmaceuticals and personal care products.

“(B) CONSULTATION.—The Administrator shall conduct the study described in subparagraph (A) in consultation with the Secretary of Health and Human Services (acting through the Commissioner of Food and Drugs), the Director of the United States Geological Survey, the heads of other appropriate Federal agencies (including the National Institute of Environmental Health Sciences), and other interested stakeholders (including manufacturers of pharmaceuticals and personal care products and consumer groups and advocates).

“(C) REPORT.—Not later than 4 years after the date of the enactment of this paragraph, the Administrator shall submit to the Congress a report on the results of the study carried out under this paragraph.

“(D) DEFINITIONS.—In this paragraph:

“(i) The term ‘personal care product’ has the meaning given the term ‘cosmetic’ in section 201 of the Federal Food, Drug, and Cosmetic Act.

“(ii) The term ‘pharmaceutical’ has the meaning given the term ‘drug’ in section 201 of the Federal Food, Drug, and Cosmetic Act.”.